“…During leishmanial infection, CD40 signaling is skewed toward the anti-inflammatory pathways involving cRaf, Syk, MEK1/2, ERK1/2, PKCδ, and PKCζ. However, stimulation with CD40L results in the skewing of the signaling toward pro-inflammatory pathway involving Lyn, PI3K, MKK3/6, p38, PKCα, and PKCβII ( Awasthi et al., 2003 ; Khan et al., 2012 , 2014 ; Mathur et al., 2004 ; Murugaiyan et al., 2006 ; Rub et al., 2009 ; Sudan et al., 2012 ). In addition, it was shown that LMP-1, a protein encoded by Epstein-Barr virus signaling like CD40, rescued certain functions—but not the full range—associated with the CD40 in CD40 −/− mice suggesting that there existed CD40L residue-specific signaling and functions ( Uchida et al., 1999 ).…”